ALB vs CDE

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in fundamental performance. Despite a strong recent price run-up (+115.4% over 1Y), the company is unprofitable (negative profit and operating margins), has negative earnings growth (YoY), and trades at an extremely high forward P/E of 82.85. While the balance sheet shows a healthy current ratio and manageable debt/equity of 0.37, the lack of Altman Z-Score and Graham Number, combined with deteriorating profitability and insider selling, raises serious concerns about sustainability. The analyst target price of $165.06 implies 13% downside from current levels, reinforcing overvaluation relative to fundamentals.

CDE presents a stark dichotomy between explosive fundamental growth and bearish market sentiment. The company maintains a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally low Debt/Equity ratio of 0.11. While the current price of $19.31 is significantly above the Graham Number ($10.5), it remains below the growth-based intrinsic value of $28.02. However, the bullish fundamental growth is heavily countered by a 0/100 technical trend and bearish insider sentiment.